MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer
- PMID: 20737563
- PMCID: PMC3940365
- DOI: 10.1002/cncr.25488
MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer
Abstract
Background: MicroRNAs (miRNAs) are small noncoding RNAs that regulate the expression of approximately 60% of all human genes. They play important roles in numerous cellular processes, including development, proliferation, and apoptosis. Currently, it is believed that miRNAs elicit their effect by silencing the expression of target genes. In this study, the authors demonstrated that miRNA-205 (miR-205) induced the expression the interleukin (IL) tumor suppressor genes IL24 and IL32 by targeting specific sites in their promoters.
Methods: The methods used in this study included transfection of small RNAs; quantitative real-time polymerase chain reaction; in situ hybridization; fluorescence-labeled in situ hybridization; cell cycle, apoptosis, cell viability, migratory, clonability, and invasion assays; immunoblotting; and luciferase reporter, nuclear run-on, and chromatin immunoprecipitation assays.
Results: The results revealed that miR-205 was silenced in prostate cancer. Its re-expression induced apoptosis and cell cycle arrest. It also impaired cell growth, migration, clonability, and invasiveness of prostate cancer cells. Micro-RNA-205 induced the expression of tumor suppressor genes IL24 and IL32 at both the messenger RNA and protein levels. The induction of in vitro transcription and enrichment of markers for transcriptionally active promoters in the IL24 and IL32 genes was observed in response to miR-205.
Conclusions: In this study, a new function for miR-205 was identified that specifically activated tumor suppressor genes by targeting specific sites in their promoters. These results corroborate a newly identified function that miRNAs have in regulating gene expression at the transcriptional level. The specific activation of tumor suppressor genes (eg, IL24, IL32) or other dysregulated genes by miRNA may contribute to a novel therapeutic approach for the treatment of prostate cancer.
Copyright © 2010 American Cancer Society.
Figures






Similar articles
-
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.Cancer Lett. 2017 Jan 28;385:150-159. doi: 10.1016/j.canlet.2016.10.028. Epub 2016 Oct 27. Cancer Lett. 2017. PMID: 27984115
-
Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.J Exp Clin Cancer Res. 2017 Nov 15;36(1):159. doi: 10.1186/s13046-017-0629-7. J Exp Clin Cancer Res. 2017. PMID: 29141691 Free PMC article.
-
MicroRNA-205 directly regulates the tumor suppressor, interleukin-24, in human KB oral cancer cells.Mol Cells. 2013 Jan;35(1):17-24. doi: 10.1007/s10059-013-2154-7. Epub 2012 Dec 3. Mol Cells. 2013. PMID: 23212344 Free PMC article.
-
Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review.Recent Adv Inflamm Allergy Drug Discov. 2022;16(1):5-15. doi: 10.2174/2772270816666220606112727. Recent Adv Inflamm Allergy Drug Discov. 2022. PMID: 35670340 Review.
-
MicroRNA mediated therapeutic effects of natural agents in prostate cancer.Mol Biol Rep. 2021 Jul;48(7):5759-5773. doi: 10.1007/s11033-021-06575-8. Epub 2021 Jul 24. Mol Biol Rep. 2021. PMID: 34304390 Review.
Cited by
-
Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription.Mol Ther Nucleic Acids. 2015 Jan 27;4(1):e222. doi: 10.1038/mtna.2014.67. Mol Ther Nucleic Acids. 2015. PMID: 25625613 Free PMC article. Review.
-
miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells.PLoS One. 2016 Aug 10;11(8):e0160961. doi: 10.1371/journal.pone.0160961. eCollection 2016. PLoS One. 2016. PMID: 27509128 Free PMC article.
-
Principles of miRNA-target regulation in metazoan models.Int J Mol Sci. 2013 Aug 7;14(8):16280-302. doi: 10.3390/ijms140816280. Int J Mol Sci. 2013. PMID: 23965954 Free PMC article. Review.
-
Nuclear microRNAs in normal hemopoiesis and cancer.J Hematol Oncol. 2017 Jan 5;10(1):8. doi: 10.1186/s13045-016-0375-x. J Hematol Oncol. 2017. PMID: 28057040 Free PMC article. Review.
-
MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics.Biomolecules. 2020 Sep 7;10(9):1285. doi: 10.3390/biom10091285. Biomolecules. 2020. PMID: 32906681 Free PMC article. Review.
References
-
- Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PMC - PubMed
-
- Carrington JC, Ambros V. Role of microRNAs in plant and animal development. Science. 2003;301(5631):336–338. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed
-
- Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11(4):441–450. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed
-
- Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–838. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PubMed
-
- Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257–2261. Available from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dop.... - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical